TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The goal of this research project is to establish that in short-term use, tolvaptan is a safe
and potentially effective new therapy for cystinuria, by conducting a short-term pilot study
of the safety and tolerability of this drug, and assess impact on urinary stone risk
parameters, among adolescent and young adult patients with clinical cystinuria.